Depo-Provera MDL 3140: what to gather before the July 27 hearing

The Depo-Provera case is moving fast, but the next step for most families is not dramatic. It is record hunting.

That may sound small. It is not. A woman may remember getting the shot every three months for years, but a claim review usually needs more than memory. It needs dates, providers, product names, imaging reports, and the meningioma diagnosis records.

Here is where things stand. The Judicial Panel on Multidistrict Litigation's July 1, 2026 report lists MDL No. 3140, In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, in the Northern District of Florida before Judge M. Casey Rodgers. The same pending-actions report lists 5,830 pending actions and 5,916 total actions.

There has also been settlement movement. Public litigation updates report that plaintiffs' leadership and Pfizer-related defendants reached an agreement in principle for eligible federal MDL claims in June. At the same time, the court kept a July 27, 2026 hearing on general causation and preemption issues.

Both facts can be true. Settlement work can be happening, and important legal issues can still matter.

Do not read "agreement in principle" as a personal answer

The words sound final. They are not final for an individual woman who is trying to figure out whether she has a claim.

As of this writing, there is no public document that lets a person plug in her medical history and know what will happen. Public terms such as eligibility rules, proof requirements, release language, deadlines, deductions, and any payment tiers have not been fully laid out for ordinary claimants.

That is why it is risky to assume the settlement news automatically covers an unfiled claim, a state-court claim, or a claim with missing records. It may. It may not. The answer depends on facts and documents.

Why records matter more than headlines

Most Depo-Provera meningioma reviews start with two basic questions:

Did the person use Depo-Provera, Depo-SubQ Provera 104, or a generic depot medroxyprogesterone acetate shot?

Was the person later diagnosed with a meningioma?

Those questions sound simple until someone tries to prove them. Birth-control shots may have been given at an OB-GYN office, a health department, a community clinic, a campus clinic, a military clinic, or a Planned Parenthood location. Insurance may have changed. Portals may be closed. A provider may have retired. The patient may have moved, changed names, or used both brand-name and generic products at different times.

That is normal. It is also why waiting can make the search harder.

Start with proof of Depo-Provera use

If you are gathering records now, look for anything that shows injection dates or product names. Useful records can include:

• OB-GYN or clinic notes showing each shot;
• pharmacy records for Depo-Provera, Depo-SubQ Provera 104, or medroxyprogesterone acetate;
• billing records and insurance explanation-of-benefits forms;
• patient portal medication lists;
• appointment histories from clinics that administered injections;
• old calendar entries, reminder cards, or after-visit summaries.

Do not throw away partial records. Even one old visit note can point to the clinic or pharmacy that has the rest.

Then gather the meningioma records

The diagnosis side matters just as much. A chart note that says "brain tumor" is usually not enough.

Try to collect MRI and CT reports, neurology notes, neurosurgery records, pathology reports, radiation records, emergency-room records tied to symptoms, and follow-up imaging. If there was surgery, the operative report and pathology report may be especially important.

Cleveland Clinic describes a meningioma as a tumor that forms in the meninges, the protective layers around the brain and spinal cord. Many meningiomas are benign, but that word can be misleading. A tumor can still press on nerves or brain tissue, cause symptoms, require surgery or radiation, and lead to years of scans.

The science being discussed in the MDL

One reason this litigation grew is the 2024 BMJ French national case-control study. The study compared women who had surgery for intracranial meningioma with matched controls. For injectable medroxyprogesterone acetate, the authors reported an increased risk linked to prolonged use, with an odds ratio around 5.55.

That is an important study. It is not a verdict. It does not prove what caused one person's tumor by itself.

Individual review still turns on the person's actual exposure history, timing, diagnosis, tumor details, medical background, and other possible risk factors.

The label history also matters. Pfizer's U.S. Depo-Provera CI prescribing information lists a recent major change for "Warnings and Precautions, Meningioma" dated December 2025. The label also says Depo-Provera CI is not recommended as a long-term birth-control method for longer than two years unless other birth-control methods are considered inadequate.

A practical checklist before July 27

If you are trying to get organized this week, make a folder and put these items in it:

1. A timeline of every Depo-Provera or generic shot you can remember.
2. Names of every clinic, doctor, pharmacy, health department, or other provider that may have given the shots.
3. Records showing injection dates, product names, or billing codes.
4. MRI and CT reports showing when the meningioma was first found.
5. Neurosurgery, neurology, radiation, and pathology records.
6. A short symptom timeline in your own words.
7. Any name changes, moves, or insurance changes that could explain missing records.

Keep originals. If you make a timeline from memory, label it as a memory aid. Do not change medical records or write on the only copy.

Bottom line

MDL 3140 is large, and the June settlement announcement is meaningful. But a public update is not the same thing as a personal case review.

If you used Depo-Provera or a generic depot medroxyprogesterone acetate shot and later learned you had a meningioma, the safest step is to collect proof of exposure and proof of diagnosis now. Those records are the foundation for any serious review, whether the claim ends up fitting a settlement process or needs a different path.

This article is attorney advertising and is for informational purposes only. It is not medical advice or legal advice, and it does not create an attorney-client relationship. Every claim depends on its own facts, records, deadlines, and applicable law.